At a time when the COVID-19 crisis is surging with each passing day and the queues outside hospitals and crematoriums are getting longer, the Union government has said that the production of Remdesivir—a crucial antiviral drug used for the treatment of COVID-19 patients—has significantly gone up by three times within a period of three weeks....

Three people, including a staff member of Shifa Hospital, were nabbed for the illegal sale of Remdesivir. The trio using the staff members got the documents of patients at the hospital and used the hospital’s fake letterhead to get hold of 30 Remdesivir injections and later sold it at a higher price. A case of...

At a time when the shortage of Remdesivir—an antiviral drug used for the treatment of COVID-19—is creating a lot of difficulties for the health authorities in the state, many are utilising this opportunity to make easy money by selling these injections at an exorbitant rate. Now, the Surat Crime Branch has nabbed a doctor and...

Unable to meet the demand of Remdesivir—a crucial antiviral drug used for COVID-19 treatment, the Gujarat government has issued guidelines related to the jab that is in huge demand owing to the massive surge in hospitalisations and deaths due to the deadly virus. The government has said that there is no evidence that suggests that...

With the demand and supply gap for Remdesivir—a crucial antiviral injection used in the treatment of COVID-19—widening with each passing day, the manufacturers of the drug have reduced their price. The move is likely to benefit thousands of COVID-affected people. The significant price reduction comes following a request made by the Union government to Remdesivir...

Despite the Gujarat government’s claims that there is sufficient stock of Remdesivir injection in the state, a long queue of people was seen outside Zydus Hospital in Ahmedabad and Kiran Hospital in Surat on Sunday to purchase the life-saving drug. The development comes a day after the Gujarat BJP president CR Patil received flak on...

The rise in demand for Remdesivir injections has led to its black marketing in the state. The arrest of seven people in connection with illegally importing the medicine has also exposed how the medicine is being procured from beyond the borders.   Probe in the case has revealed that one of the accused Shabbir Ahmed...

The crime branch is investigating a case in which Remdesivir injections were illegally imported from Bangladesh and sold at a high price in Gujarat. The Crime Branch arrested seven people in connection with the case.    Among those arrested are a Bangladeshi national as well as a husband-wife duo who runs a company Nilkanth Elixir...

The US Department of Health and Human Services announced that it will be buying up virtually the entire produced stock of remdesivir from manufacturer Gilead till September. The agency said it secured more than 500,000 remdesivir courses for US hospitals through September. That represents all of Gilead’s projected production for July and 90 per cent...

Maharashtra will begin trials for remdesivir—a drug that has been touted as a success in the battle against COVID-19. The state’s COVID-19 task force that comprises doctors who look into clinical management and reports to Chief Minister Uddhav Thackeray had suggested its use to save lives, sources said. They have asked the Chief Minister to...

The Union government on Tuesday said it has approved Gilead Sciences Inc’s antiviral drug remdesivir for emergency use in treating COVID-19 patients. Remdesivir is the first drug to show improvement in COVID-19 patients in formal clinical trials. It was granted emergency use authorisation by the US Food and Drug Administration last month and has received...

India’s Jubilant Life Sciences Ltd has signed a non-exclusive licensing agreement for selling Gilead Sciences Inc’s experimental COVID-19 treatment remdesivir in 127 countries, including India. The drug earlier this month received the US Food and Drug Administration’s emergency use authorisation to treat COVID-19 patients. Jubilant also gets the rights to...